
Misook Yu
Supervisory Patent Examiner (ID: 1022, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 859 |
| Issued Applications | 261 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1305853
[patent_doc_number] => 06617118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules'
[patent_app_type] => B2
[patent_app_number] => 09/810379
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 17564
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810379 | Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules | Mar 15, 2001 | Issued |
Array
(
[id] => 6343893
[patent_doc_number] => 20020035080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'cDNA encoding P2P proteins and use of P2P cDNA-derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans'
[patent_app_type] => new
[patent_app_number] => 09/811045
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6448
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035080.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811045
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811045 | cDNA encoding P2P proteins and use of P2P cDNA-derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans | Mar 15, 2001 | Abandoned |
Array
(
[id] => 6141551
[patent_doc_number] => 20020001806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Caspase-3s splicing variant'
[patent_app_type] => new
[patent_app_number] => 09/809905
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8258
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20020001806.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809905 | Caspase-3s splicing variant | Mar 15, 2001 | Abandoned |
Array
(
[id] => 1080954
[patent_doc_number] => 06835816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-28
[patent_title] => 'Mammalian tumor susceptibility genes and their uses'
[patent_app_type] => B2
[patent_app_number] => 09/804690
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15437
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835816.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804690
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804690 | Mammalian tumor susceptibility genes and their uses | Mar 11, 2001 | Issued |
Array
(
[id] => 6817713
[patent_doc_number] => 20030068671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/800321
[patent_app_country] => US
[patent_app_date] => 2001-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54859
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068671.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800321
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800321 | Novel proteins and nucleic acids encoding same | Mar 4, 2001 | Abandoned |
Array
(
[id] => 675651
[patent_doc_number] => 07087431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-08
[patent_title] => 'Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor'
[patent_app_type] => utility
[patent_app_number] => 09/796830
[patent_app_country] => US
[patent_app_date] => 2001-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6571
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/087/07087431.pdf
[firstpage_image] =>[orig_patent_app_number] => 09796830
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/796830 | Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor | Feb 28, 2001 | Issued |
Array
(
[id] => 1370280
[patent_doc_number] => 06558668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-06
[patent_title] => 'Methods for detection and treatment of neural cancers'
[patent_app_type] => B2
[patent_app_number] => 09/795714
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 18661
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795714
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795714 | Methods for detection and treatment of neural cancers | Feb 27, 2001 | Issued |
Array
(
[id] => 6593785
[patent_doc_number] => 20020042098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => '32253 transferase family members and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/795501
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 42571
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042098.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795501
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795501 | 32253 transferase family members and uses therefor | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6032854
[patent_doc_number] => 20020019030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => '25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/798029
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 50873
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019030.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798029 | 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor | Feb 26, 2001 | Abandoned |
Array
(
[id] => 6242189
[patent_doc_number] => 20020045212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Novel human GTPase activator proteins'
[patent_app_type] => new
[patent_app_number] => 09/802127
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 36353
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045212.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802127
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802127 | Novel human GTPase activator proteins | Feb 25, 2001 | Abandoned |
| 09/792561 | Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response | Feb 22, 2001 | Abandoned |
Array
(
[id] => 6774118
[patent_doc_number] => 20030017456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Diagnosis and treatment and related preparations'
[patent_app_type] => new
[patent_app_number] => 09/792440
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34266
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017456.pdf
[firstpage_image] =>[orig_patent_app_number] => 09792440
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/792440 | Diagnosis and treatment and related preparations | Feb 22, 2001 | Abandoned |
Array
(
[id] => 6552271
[patent_doc_number] => 20020111303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Diagnostic and therapeutic methods'
[patent_app_type] => new
[patent_app_number] => 09/792439
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 33898
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09792439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/792439 | Diagnostic and therapeutic methods | Feb 22, 2001 | Abandoned |
Array
(
[id] => 6278459
[patent_doc_number] => 20020107190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Novel genes and expression products therefrom'
[patent_app_type] => new
[patent_app_number] => 09/788476
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12234
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788476 | Novel genes and expression products therefrom | Feb 20, 2001 | Abandoned |
Array
(
[id] => 5859009
[patent_doc_number] => 20020123092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Regulatory elements from RP1 gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/790228
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4179
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123092.pdf
[firstpage_image] =>[orig_patent_app_number] => 09790228
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/790228 | Regulatory elements from RP1 gene and uses thereof | Feb 20, 2001 | Abandoned |
Array
(
[id] => 6381932
[patent_doc_number] => 20020120004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Methods and compositions for the identification, assessment, prevention and therapy of human cancers'
[patent_app_type] => new
[patent_app_number] => 09/788099
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49746
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20020120004.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788099
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788099 | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | Feb 15, 2001 | Abandoned |
Array
(
[id] => 6552042
[patent_doc_number] => 20020111289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'CDK4 is a target of c-MYC'
[patent_app_type] => new
[patent_app_number] => 09/780566
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7053
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111289.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780566
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780566 | CDK4 is a target of c-MYC | Feb 11, 2001 | Abandoned |
Array
(
[id] => 6471039
[patent_doc_number] => 20020022036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Method for inducing an anti-tumor and anti-cachexia immune response in mammals'
[patent_app_type] => new
[patent_app_number] => 09/781023
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5764
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022036.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781023
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781023 | Method for inducing an anti-tumor and anti-cachexia immune response in mammals | Feb 8, 2001 | Abandoned |
Array
(
[id] => 6546351
[patent_doc_number] => 20020110893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Novel human bcl-x-like proteins and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/773774
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7970
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110893.pdf
[firstpage_image] =>[orig_patent_app_number] => 09773774
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/773774 | Novel human bcl-x-like proteins and polynucleotides encoding the same | Jan 30, 2001 | Abandoned |
Array
(
[id] => 5873430
[patent_doc_number] => 20020048571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Chimeric polypeptides of serum albumin and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 09/768183
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16911
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048571.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768183
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768183 | Chimeric polypeptides of serum albumin and uses related thereto | Jan 22, 2001 | Abandoned |